This is a preview of subscription content, log in to check access.
Baumgartner R, et al. One unexpected increase in clinical and MRI disease activity after first course of Alemtuzumab besides many positive outcomes. Swiss Medical Weekly 146 (Suppl. 219): 97S, Sep 2016. Available from: URL: https://smw.ch/ [abstract] - SwitzerlandGoogle Scholar